MSMB, microseminoprotein beta, 4477

N. diseases: 195; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0858321
Disease: Plasmodium vivax infection
Plasmodium vivax infection
0.010 Biomarker disease BEFREE Anti-MSP-10 IgG indicates recent exposure to Plasmodium vivax infection in the Peruvian Amazon. 31770108 2020
CUI: C0013363
Disease: Dysautonomia
Dysautonomia
0.010 Biomarker disease BEFREE Subsequently, the diagnosis was changed to PSP due to hypometric downward gaze, reduced blink frequency, symmetric bradykinesia, rigidity, and the absence of autonomic dysfunction. 31216016 2019
CUI: C0027126
Disease: Myotonic Dystrophy
Myotonic Dystrophy
0.010 Biomarker disease BEFREE Here, we report a patient with the coexistence of PSP with pontocerebellar atrophy and myotonic dystrophy type 1 (DM1). 31216016 2019
CUI: C0036690
Disease: Septicemia
Septicemia
0.010 Biomarker disease BEFREE <b>Aim:</b> To assess the prognostic value for 28-day mortality of PSP in critically ill patients with sepsis. 31621373 2019
CUI: C0036916
Disease: Sexually Transmitted Diseases
Sexually Transmitted Diseases
0.010 GeneticVariation group BEFREE Hitherto, these conditions have been not studied in Mexico yet, neither if sexually transmitted infections could modify the MSMB and PC association. 30774776 2019
CUI: C0040592
Disease: Trachoma
Trachoma
0.010 Biomarker disease BEFREE The effect of biannual versus annual azithromycin distribution for trachoma control on serological response to merozoite surface protein 1 (MSP-1<sub>19</sub>), a surrogate for malaria incidence, was evaluated among children in Niger. 31796025 2019
CUI: C0043207
Disease: Wolfram Syndrome
Wolfram Syndrome
0.010 AlteredExpression disease BEFREE Circulating PSP/reg levels are also increased in some patients with Wolfram syndrome. 30914711 2019
CUI: C0243026
Disease: Sepsis
Sepsis
0.010 Biomarker disease BEFREE <b>Aim:</b> To assess the prognostic value for 28-day mortality of PSP in critically ill patients with sepsis. 31621373 2019
CUI: C0280100
Disease: Solid Neoplasm
Solid Neoplasm
0.010 Biomarker phenotype BEFREE The combination of PSP@MB and the use of ultrasound can efficiently enhance accumulation, extravasation and penetration into solid tumors. 31814720 2019
CUI: C0343723
Disease: Neonatal chlamydial conjunctivitis
Neonatal chlamydial conjunctivitis
0.010 Biomarker disease BEFREE The effect of biannual versus annual azithromycin distribution for trachoma control on serological response to merozoite surface protein 1 (MSP-1<sub>19</sub>), a surrogate for malaria incidence, was evaluated among children in Niger. 31796025 2019
CUI: C0525045
Disease: Mood Disorders
Mood Disorders
0.010 Biomarker group BEFREE Within the ID cohort, behaviour impairment and MSP (i.e. moderate, severe, or profound) ID was associated with increased prescription of anxiolytics, both among those with anxiety (1.15 [1.03-1.30] for behaviour impairment and 1.23 [1.10-1.38] for MSP ID) and among those with mood disorders (1.14 [0.97-1.35] for behaviour impairment and 1.26 [1.04-1.52] for MSP ID). 31370823 2019
CUI: C0740394
Disease: Hyperuricemia
Hyperuricemia
0.010 Biomarker disease BEFREE Our findings provide new evidence for the supplementary therapeutic potential of HAA-PSP with allopurinol on hyperuricemia and inflammation-related syndromes. 31091873 2019
CUI: C0751072
Disease: Frontotemporal Lobar Degeneration
Frontotemporal Lobar Degeneration
0.010 GeneticVariation disease BEFREE <b>Objectives:</b> The present study is geared to learning about the patterns of tau seeding and cells involved following unilateral inoculation in the corpus callosum of homogenates from sporadic Alzheimer's disease (AD), primary age-related tauopathy (PART: neuronal 4Rtau and 3Rtau), pure aging-related tau astrogliopathy (ARTAG: astroglial 4Rtau with thorn-shaped astrocytes TSAs), globular glial tauopathy (GGT: 4Rtau with neuronal tau and specific tau inclusions in astrocytes and oligodendrocytes, GAIs and GOIs, respectively), progressive supranuclear palsy (PSP: 4Rtau with neuronal inclusions, tufted astrocytes and coiled bodies), Pick's disease (PiD: 3Rtau with characteristic Pick bodies in neurons and tau containing fibrillar astrocytes), and frontotemporal lobar degeneration linked to P301L mutation (FTLD-P301L: 4Rtau familial tauopathy). 31191295 2019
CUI: C0871189
Disease: Psychotic symptom
Psychotic symptom
0.010 AlteredExpression phenotype BEFREE Two experts in clinical psychology conducted the interviews and independently rated other assessment tools (PANSS, GAF and PSP) to determine severity of psychotic symptoms and levels of functionality. 30832192 2019
CUI: C1145628
Disease: Autonomic nervous system disorders
Autonomic nervous system disorders
0.010 Biomarker group BEFREE Subsequently, the diagnosis was changed to PSP due to hypometric downward gaze, reduced blink frequency, symmetric bradykinesia, rigidity, and the absence of autonomic dysfunction. 31216016 2019
CUI: C1274728
Disease: Atrophic acne scar
Atrophic acne scar
0.010 Biomarker disease BEFREE PSP technique was found to be a safe and cost-effective treatment option for atrophic acne scars. 31414709 2019
ST segment elevation myocardial infarction
0.010 Biomarker disease BEFREE Optimal BRS implantation, as assessed by PSP score, was associated with better post-procedural QCA parameters in STEMI. 30398966 2019
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.010 Biomarker group BEFREE Moreover, MSP ID was associated with increased prescription of GABA-agonists among those with anxiety (1.23 [1.10-1.38]). 31370823 2019
CUI: C3811918
Disease: GRN-related frontotemporal dementia
GRN-related frontotemporal dementia
0.010 GeneticVariation disease BEFREE <b>Objectives:</b> The present study is geared to learning about the patterns of tau seeding and cells involved following unilateral inoculation in the corpus callosum of homogenates from sporadic Alzheimer's disease (AD), primary age-related tauopathy (PART: neuronal 4Rtau and 3Rtau), pure aging-related tau astrogliopathy (ARTAG: astroglial 4Rtau with thorn-shaped astrocytes TSAs), globular glial tauopathy (GGT: 4Rtau with neuronal tau and specific tau inclusions in astrocytes and oligodendrocytes, GAIs and GOIs, respectively), progressive supranuclear palsy (PSP: 4Rtau with neuronal inclusions, tufted astrocytes and coiled bodies), Pick's disease (PiD: 3Rtau with characteristic Pick bodies in neurons and tau containing fibrillar astrocytes), and frontotemporal lobar degeneration linked to P301L mutation (FTLD-P301L: 4Rtau familial tauopathy). 31191295 2019
CUI: C0013884
Disease: Filarial Elephantiases
Filarial Elephantiases
0.010 Biomarker disease BEFREE The seroconversion rate to P. malariae MSP-119 and the LF Wb123 and Bm14 antigens each decreased significantly in one of the two districts. 29444078 2018
CUI: C0023281
Disease: Leishmaniasis
Leishmaniasis
0.010 Biomarker disease BEFREE Symptomatic leishmaniasis causes considerable human morbidity in endemic regions.The Leishmania spp. evade host microbicidal mechanisms partially through virulence-associated proteins such as the major surface protease (MSP or GP63), to inactivate immune factors in the host environment. 29921321 2018
CUI: C0029463
Disease: Osteosarcoma
Osteosarcoma
0.010 Biomarker disease BEFREE These observations indicate that low concentrations of MSP-4 can help induce the apoptosis of MG63 through a Fas/FasL- and mitochondria-mediated pathway and suggest a potentially innovative alternative to the treatment of human osteosarcoma. 29301308 2018
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE Using data from a prospective cohort study on a consecutive sample assessed at 4 time points, presurgery (T1), 48 hours (T2), 4 months (T3), and 5 years postsurgery (T4), we sought to examine women's PSP trajectories using assessments of pain at T3 and T4. 29419656 2018
CUI: C0032285
Disease: Pneumonia
Pneumonia
0.010 AlteredExpression disease BEFREE Furthermore, compound 5 showed in vivo activity against the experimental murine pneumonia model due to penicillin-resistant Streptococcus pneumoniae ( PRSP) and favorable profiles in preliminary toxicological and nonclinical pharmacokinetic studies. 30063826 2018
CUI: C0154084
Disease: Stage 0 Breast Carcinoma
Stage 0 Breast Carcinoma
0.010 GeneticVariation disease BEFREE This retrospective series includes all of the 1531 cases of invasive and in situ breast cancer (DCIS, ductal carcinoma in situ) that were newly diagnosed in two certified breast care centers in Münster in the period 2006-2012 among women in the MSP target population. 30149831 2018